Related Experiment Video
Updated: Aug 9, 2025

Transcriptome Profiling of In-Vivo Produced Bovine Pre-implantation Embryos Using Two-color Microarray Platform
Published on: January 30, 2017
PsA inhibits the development of bovine embryos through epigenetic and oxidative stress
Xin Ma1, Chenglin Zhan1, Panpan Ma1,2
1College of Animal Science and Technology, Jilin Agricultural University, Changchun, Jilin, China.
Objective:
Histone deacetylases (HDACs) are the key regulators involved in the process of embryo development and tumor progression and are often dysregulated in numerous disordered cells, including tumor cells and somatic cell nuclear transfer (SCNT) embryos. Psammaplin A (PsA), a natural small-molecular therapeutic agent, is a potent histone deacetylase inhibitor (HDACi) that alters the regulation of histone.
Samples:
Approximately 2,400 bovine parthenogenetic (PA) embryos.
Procedures:
To investigate the effect of PsA on bovine preimplanted embryos, we analyzed the preimplantation development of PA embryos treated with PsA in this study.
Results:
The blastocyst formation rate of bovine PA embryos decreased sharply with an increase in concentration and duration. Furthermore, the expression of the pluripotency-related gene Nanog was decreased, and the inhibitory effects on histone deacetylases 1 (HDAC1) and DNA methylation transferase 1 (DNMT1) were observed in bovine PA embryos. The acetylation level of histone H3 lysine 9 (H3K9) was enhanced by a PsA treatment of 10 μM for 6 h, while the DNA methylation appeared unchanged. Interestingly, we also found that PsA treatment enhanced the intracellular reactive oxygen species (ROS) generation and decreased the intracellular mitochondrial membrane potential (MMP)- and superoxide dismutase 1 (SOD1)-induced oxidative stress. Our findings improve the understanding of HDAC in embryo development and provide a theoretical basis and reproduction toxicity evaluation for the application of PsA.
Clinical Relevance:
These results indicate that PsA inhibits the development of bovine preimplantation PA embryos, supplying data for the PsA clinical application concentration to avoid reproductive toxicity. In addition, the reproduction toxic effect of PsA may be modulated through increased oxidative stress on the bovine PA embryo, suggesting that PsA in combination with antioxidants, for example, melatonin, might be an effective clinical application strategy.
Insights
Psammaplin A (PsA) inhibits bovine embryo development by decreasing pluripotency gene expression and increasing oxidative stress. This suggests careful clinical application of PsA to avoid reproductive toxicity.
Area of Science:
- Reproductive biology and developmental toxicology.
- Epigenetics and its role in early development.
- Histone deacetylase inhibitors (HDACi) and their effects on cellular processes.
Background:
- Histone deacetylases (HDACs) regulate crucial processes like embryo development and tumor progression.
- HDACs are frequently dysregulated in tumor cells and somatic cell nuclear transfer (SCNT) embryos.
- Psammaplin A (PsA) is a potent HDAC inhibitor with potential therapeutic applications.
Purpose of the Study:
- To investigate the impact of PsA on the preimplantation development of bovine parthenogenetic (PA) embryos.
- To analyze the effects of PsA on key developmental genes and epigenetic modifications in bovine embryos.
- To evaluate the potential reproductive toxicity of PsA.
Main Methods:
- Treatment of approximately 2,400 bovine PA embryos with varying concentrations and durations of PsA.
- Analysis of blastocyst formation rates.
- Assessment of pluripotency gene (Nanog) expression.
- Measurement of histone acetylation (H3K9), DNA methylation, reactive oxygen species (ROS) generation, mitochondrial membrane potential (MMP), and superoxide dismutase 1 (SOD1) activity.
Main Results:
- PsA significantly reduced blastocyst formation rates in a dose- and time-dependent manner.
- PsA decreased Nanog expression and inhibited HDAC1 and DNMT1.
- PsA enhanced H3K9 acetylation, increased ROS generation, and decreased MMP and SOD1 activity, indicating oxidative stress.
Conclusions:
- PsA inhibits bovine preimplantation PA embryo development, highlighting the need for caution in clinical applications to prevent reproductive toxicity.
- The reproductive toxicity of PsA may be linked to increased oxidative stress in embryos.
- Combining PsA with antioxidants like melatonin could be a viable strategy for clinical use, mitigating adverse effects.
Related Concept Videos
Teratogenicity
Nondisjunction
Epigenetic Regulation
X-chromosome...

